Great investment and you will be rewarded well at these levels. Evonik a company that does 14.4 billion in sales doesn't announce they are excited to bring brilacidin franchise to finish line for the fun of it. They wouldn't be involved in a small cash starved start up unless there was much more then meets the eye, a major third party player about to be announced makes a lot of sense. Admittedly its been a long frustrating journey for those like myself who have bought and believed for years. Its takes resolve and patience which is being tested now. In most business models that turn out successful they usually cost more and take longer then expected. Why should ipix be any different. Short's have done well but game is by no means over.